Infant Formula Ingredients Market ( By Types - Carbohydrates, Oils & Fats, Proteins, Vitamins & Minerals, Prebiotics; By Form - Powder, Liquid & Semi-Liquid; By Application - Growing-Up Milk (Infants Over 12 Months), Standard Infant Formula (0–6-Month-Old Infant), Follow-On Formula (6–12 Month-Old Infant), Specialty Formula) - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

A number of different types of nutrition are for infants are available in the market. The infant formulas comprise of purified cow’s milk as a source of protein, blend of fat source form vegetable oils, vitamin-mineral mix, lactose as a carbohydrate source, and other ingredients depends on the processes of manufacturing. During last few years, the infant formula industry has been growing rapidly owing to rising number of working women population and increase in per capita income. Infant formula ingredients help in improving the health of the infants and ultimately help in minimizing the cost of hospital. Increasing awareness among the people has increased the adoption of these types of nutrition.

Market Dynamics

The infant formula ingredients market is majorly driven by increasing middle class population Asia Pacific, increasing number of working women, and rising awareness about natural infant feeding. During last few years, there is an increase in the prevalence of malnutrition or infants suffering from nutrition deficiency. Thus, infant formula ingredients hahs gained attention of various people across the globe. Additionally, large population base, rapid economic development and high birth rate will support the growth of the market. Inability of mothers to lactate sufficiently, preference for convenient feeding, and increase in awareness for natural infant feeding will boost the growth of the market.

However, some of the nutrition is expensive, and lack of awareness in developing region may slow the growth of the market.

Market Classification and Overview

The global infant formula ingredients market is majorly segmented on the basis of types and end users. On the basis of types, the market is segmented into carbohydrates, oils & fats, proteins, vitamins & minerals, prebiotics, and others. On the basis of forms, the market is segmented into powder and liquid & semi-liquid. On the basis of application, the market is segmented into growing-up milk (infants over 12 months), standard infant formula (0–6-month-old infant), follow-on formula (6–12 month-old infant), specialty formula, and others.

Regional Overview

America accounts for the largest share in the global infant formula ingredients market owing to the high healthcare spending, and huge awareness about the infants’ nutrition. Additionally, increasing government support in this region is supporting the research institute for researcher and development will support the growth of the market.

Europe accounts for the second leading market which is followed by the Asia Pacific. Availability of funds and strong government support for will drive the European market during the forecast period 2018-2026. The Asia Pacific is the fastest growing market owing to the presence of a huge population pool, presence of rapidly developing economies, and increasing government support.

On the other hand, owing to limited availability of fund and poor economy in Africa region the infant formula ingredients market in the Middle East & Africa region is at last position. However, in near future the market will expected to have a huge potential owing to huge untapped opportunity.

Report Coverage

Market

Infant Formula Ingredients Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Form, Application, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

The global infant formula ingredients market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2026, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2026 as the forecast period to estimate the market size for infant formula ingredients.

Market Participants

  • Arla Foods Amba
  • Vitablend Nederland B.V.
  • Carbery Food Ingredients Limited
  • Fonterra Co-Operative Group Limited
  • Aarhuskarlshamn AB
  • Royal Frieslandcampina N.V.
  • Sachsenmilch Leppersdorf GmbH
  • BASF SE
  • Koninklijke DSM N.V.
  • Chr. Hansen Holding A/S
  • Glanbia PLC
  • Kerry Group PLC

Market Segmentation

Market By Types

  • Carbohydrates
  • Oils & Fats
  • Proteins
  • Vitamins & Minerals
  • Prebiotics
  • Others

 Market By Application

  • Growing-Up Milk (Infants Over 12 Months)
  • Standard Infant Formula (0–6-Month-Old Infant)
  • Follow-On Formula (6–12 Month-Old Infant)
  • Specialty Formula
  • Others

Market By Form

  • Powder
  • Liquid & Semi-Liquid

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary